本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

XILIO THERAPEUTICS, INC.

0.8100
-0.0050-0.61%
盘后0.81000.00000.00%16:02 EDT
成交量:24.71万
成交额:20.69万
市值:4,193.67万
市盈率:-0.74
高:0.8600
开:0.8305
低:0.8001
收:0.8150
数据加载中...
2024/05/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/14

重要事件披露

Form 8-K - Current report
2024/05/03

SEC问询函

Form CORRESP - Correspondence
2024/04/05

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/04/05

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/04/01

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/04/01

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/04/01

重要事件披露

Form 8-K - Current report
2024/03/28

重要事件披露

Form 8-K - Current report
2024/03/28

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/06

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/05

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/19

重要事件披露

Form 8-K - Current report
2024/01/04

重要事件披露

Form 8-K - Current report
2023/12/07

重要事件披露

Form 8-K - Current report
2023/11/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/10

重要事件披露

Form 8-K - Current report
2023/11/10

[修订]季度报告

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
2023/11/10

[修订]季度报告

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]